References
- Lechien JR, Chiesa-Estomba CM, De SD, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277(8):2251–2261.
- Lee Y, Min P, Lee S, et al. Prevalence and duration of acute loss of smell or taste in COVID-19 patients. J Korean Med Sci. 2020;35(18):e174.
- Ackerman BH, Kasbekar N. Disturbances of taste and smell induced by drugs. Pharmacotherapy. 1997;17(3):482–496.
- Henkin RI. Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction. Drug Saf. 1994;11(5):318–377.
- Stricker BH, Van Riemsdijk MM, Sturkenboom MC, et al. Taste loss to terbinafine: a case-control study of potential risk factors. Br J Clin Pharmacol. 1996;42(3):313–318.
- Wang Y, Lipner SR. Retrospective analysis of smell and taste disturbances associated with dermatologic medications reported to the United States Food and Drug Administration and relevance to COVID-19 infections. J Am Acad Dermatol. 2020;83(2):682–684.
- Halpern SM, Todd PM, Kirby JD. Loss of taste associated with isotretinoin. Br J Dermatol. 1996;134(2):378.
- Heise E, Schnuch A. Taste and olfactory disturbances after treatment for acne with isotretinoin, a 13-cis-isomer of retinoic acid. Eur Arch Otorhinolaryngol. 1990;247(6):382–383.
- Kartal D, Yaşar M, Kartal L, et al. Effects of isotretinoin on the olfactory function in patients with acne. An Bras Dermatol. 2017;92(2):191–195.